In addition, in a HER2-transgenic mouse model of breast cancer, the group of mice treated with anti-HER2 CAR T cells and repeated injections of anti-PD-1 mAb after tumor implantation showed greater CD8+ CAR T cell function with less T cell exhaustion and enhanced tumor cell killing [36]. The gene discussed is PDCD1; the disease is breast cancer.